Back
Koninklijke Philips NV Vs. Akari Therapeutics PLC Industry Stock Comparison
Buy
53
PHG
Koninklijke Philips NV
Last Price:
25.75
Seasonality Move:
6.55%
Sell
25
AKTX
Akari Therapeutics PLC
Last Price:
2.30
Seasonality Move:
-8%
Buy
53
Koninklijke Philips NV (PHG)
is a Buy
Is Koninklijke Philips NV a Buy, Sell or Hold?
- The current Koninklijke Philips NV [PHG] share price is $25.96. The Score for PHG is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- PHG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy, Sell or Hold?
- The current Akari Therapeutics PLC [AKTX] share price is $2.24. The Score for AKTX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- AKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHG Stock Price Chart
What is Koninklijke Philips NV's stock price today?
-
The Koninklijke Philips NV share price today is $25.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHG is experiencing slight selling pressure.
AKTX Stock Price Chart
What is Akari Therapeutics PLC's stock price today?
-
The Akari Therapeutics PLC share price today is $2.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing selling pressure, which indicates risk of future bearish movement.
PHG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.34 | Sell |
| Relative Strength Index (14 RSI): | 30.61 | Sell |
| Chaikin Money Flow: | -125233 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.46 - 31.96) | Sell |
| Bollinger Bands (100): | (26.57 - 31.35) | Sell |
AKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 39.49 | Sell |
| Chaikin Money Flow: | -4833 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.24 - 2.62) | Sell |
| Bollinger Bands (100): | (2.62 - 3.7) | Sell |
PHG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.65 | Sell |
| 20-day SMA: | 28.48 | Sell |
| 50-day SMA: | 30.22 | Sell |
| 200-day SMA: | 25.69 | Buy |
| 8-day EMA: | 26.64 | Sell |
| 20-day EMA: | 27.99 | Sell |
| 50-day EMA: | 29.16 | Sell |
| 200-day EMA: | 26.6 | Sell |
AKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.36 | Sell |
| 20-day SMA: | 2.36 | Sell |
| 50-day SMA: | 2.8 | Sell |
| 200-day SMA: | 2.56 | Sell |
| 8-day EMA: | 2.35 | Sell |
| 20-day EMA: | 2.45 | Sell |
| 50-day EMA: | 2.72 | Sell |
| 200-day EMA: | 3 | Sell |
Koninklijke Philips NV Earnings Growth & PHG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.46 per share.
Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
Koninklijke Philips NV Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akari Therapeutics PLC Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||